PLoS ONE · 2016 · 57 citations · 44 references
Life SciencesCell BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCell MigrationEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionEpithelial-mesenchymal BalanceEpithelial-mesenchymal TransformationEpithelial-mesenchymal Transition In CancerMelanocytic Tumor Molecular PathologyMelanocytic Tumor ProgressionMelanoma ProgressionMetastatic Melanoma TreatmentPrimary Tumor Characterization
Lumican, a small leucine rich proteoglycan, inhibits MMP-14 activity and melanoma cell migration in vitro and in vivo. Snail triggers epithelial-mesenchymal transitions endowing epithelial cells with migratory and invasive properties during tumor progression. The aim of this work was to investigate lumican effects on MMP-14 activity and migration of Snail overexpressing B16F1 (Snail-B16F1) melanoma cells and HT-29 colon adenocarcinoma cells. Lumican inhibits the Snail induced MMP-14 activity in B16F1 but not in HT-29 cells. In Snail-B16F1 cells, lumican inhibits migration, growth, and melanoma primary tumor development. A lumican-based strategy targeting Snail-induced MMP-14 activity might be useful for melanoma treatment.
44
Snail blocks the cell cycle and confers resistance to cell death
Sonia Vega, Aixa V. Morales, Oscar H. Ocaña et al. · Genes & Development · 2004 · 874 citations · Full text